JPS5848064B2 - Analysis method for urine constituent substances - Google Patents
Analysis method for urine constituent substancesInfo
- Publication number
- JPS5848064B2 JPS5848064B2 JP1046179A JP1046179A JPS5848064B2 JP S5848064 B2 JPS5848064 B2 JP S5848064B2 JP 1046179 A JP1046179 A JP 1046179A JP 1046179 A JP1046179 A JP 1046179A JP S5848064 B2 JPS5848064 B2 JP S5848064B2
- Authority
- JP
- Japan
- Prior art keywords
- eluent
- concentration
- acetonitrile
- chloride
- urine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
【発明の詳細な説明】
本発明はイオン交換クロマトグラフイーによる尿構成物
質類の分析方法に係り、特に該方法に用いる溶離液の改
良に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for analyzing urine constituents by ion exchange chromatography, and particularly to improvements in eluents used in the method.
尿構成物質は約2000成分にも耘よぶと云われ、しか
もこれら成分の多くは人体の病態に密接に関連し、特定
の病患に対して特異的に増減することが知られている。It is said that there are approximately 2,000 components of urine, and many of these components are closely related to the pathological conditions of the human body, and are known to increase or decrease specifically in response to specific diseases.
従って、尿構成物質を分析することは、患者の病態診断
、治療むよび人工臓器の開発等に大きく寄与するものと
期待されている。Therefore, analysis of urine constituent substances is expected to greatly contribute to the diagnosis and treatment of patient conditions, the development of artificial organs, and the like.
従来の分析方法として、尿中の個々の構成物質について
定量する吸光々度法や酢酸と酢酸アンモニウムの緩衝液
を溶離液として用いる陰イオン交換クロマトグラフイー
が一般に知られている。As conventional analytical methods, the absorbance measurement method for quantifying individual constituent substances in urine and anion exchange chromatography using a buffer solution of acetic acid and ammonium acetate as an eluent are generally known.
しかし、前者の吸光々度法によるとき&も共存する他の
戒分に妨害される場合もあり、また試料の前処理等に長
時間を要することもあって、尿構戒物質と生理的機能と
の相関々係を必ずしも明らかにできないという欠点があ
る。However, when using the former absorbance measurement method, it may be interfered with by other coexisting substances, and it may take a long time to pre-process the sample. The disadvantage is that it is not always possible to clarify the correlation between
他方、後者の陰イオン交換クロマトグラフイーは、試料
の前処理をほとんど要することなく尿本来の状態の1ヘ
で分析可能であること、1回の分析で得られる情報が極
めて多いため個々の成分の定性、定量分析とともに、尿
構成物質組或と病気との相関々係についても解析が可能
になるという利点があるが、現状では未だ以下の欠点が
避けられない。On the other hand, the latter method, anion exchange chromatography, requires almost no pretreatment of the sample and can be analyzed in its original state. Although it has the advantage of being able to analyze the correlation between the composition of urine constituents and diseases as well as the qualitative and quantitative analysis of urine, the following drawbacks are still unavoidable at present.
すなわち、この方法の1つに、溶離液として酢酸と酢酸
アンモニウムの緩衝液を、検出器として紫外吸光々度計
をそれぞれ用いて溶離液の濃度を直線的に上昇させるこ
とを要旨とする濃度こう配溶離法によって尿構成物質を
分離、展開する方法が知られているがC C t D
t S cott 外3:Am,J,Ct:n,Pa
th,53,701(1868)〕、この方法によると
きは、1試料の分析に40時間を費す等のため分析時間
が非常に長くなる上に、溶離液として用いる酢酸系の緩
衝液は紫外吸収を示すので、ベースラインの上昇にとも
なう検出精度の低下と検出波長の制限という欠点が避け
られない。That is, one of these methods is a concentration gradient method in which the concentration of the eluent is linearly increased using a buffer solution of acetic acid and ammonium acetate as the eluent and an ultraviolet absorption spectrophotometer as the detector. A method of separating and developing urine constituents by elution method is known, but C C t D
t S cott Outside 3: Am, J, Ct: n, Pa
th, 53, 701 (1868)], when this method is used, the analysis time is very long as it takes 40 hours to analyze one sample, and the acetic acid-based buffer used as the eluent is ultraviolet. Since it exhibits absorption, it inevitably suffers from the disadvantages of a decrease in detection accuracy as the baseline rises and a limitation on the detection wavelength.
前記欠点を改善し、例えば2時間で尿構成物質約100
成分を分離、検出する方法も開発されているが〔瀬田外
4:分化,73 ,27(1978),:]、この方法
による場合でも、分析結果を病態把握に利用するにはな
お・時間がか\りすぎる上に、溶離液は酢酸系の緩衝液
を適用しているため紫外吸光上依然として問題がある。Improves the above disadvantages, for example, reduces urine constituents by about 100% in 2 hours.
A method for separating and detecting components has also been developed [Setagai 4: Differentiation, 73, 27 (1978)], but even with this method, it still takes time to use the analysis results to understand pathological conditions. In addition to being too hot, the eluent used is an acetic acid-based buffer, which still poses a problem in terms of ultraviolet light absorption.
前記紫外吸収上の問題点について布延するに、紫外吸光
々度計は他の検出器、例えばけい光検出器等に比して取
扱いが容易であること、反応試薬を要しないこと等の利
点があるため賞用されているが、検出波長は溶離液が紫
外吸収性の酢酸系緩衝液である場合には通常2 5 4
nmと2 8 0 nmに限られ、他の領域、特に有
効とされる短波長側、例えば2 3 4 nmに吸収極
大のあるクレアチニン等の検出は不可能であった。Regarding the above-mentioned problems regarding ultraviolet absorption, the advantages of ultraviolet absorption spectrometers include that they are easier to handle than other detectors, such as fluorescence detectors, and do not require reaction reagents. However, the detection wavelength is usually 2 5 4 when the eluent is an ultraviolet absorbing acetic acid buffer.
It has been impossible to detect creatinine, which has an absorption maximum at 234 nm, and other wavelengths, such as creatinine, which has an absorption maximum at 234 nm.
そのため、尿構成物質の組成と病態との関連をより詳し
く追求して行く上で限界があった。Therefore, there were limitations in pursuing in more detail the relationship between the composition of urine constituents and pathological conditions.
本発明の目的は、前記従来技術の欠点をなくし検出精度
の向上と検出波長域の拡大並びに分析時間の大巾な短縮
化が可能な尿構成物質類のイオン交換クロマトグラフイ
ーによる分析方法を提供するにある。An object of the present invention is to provide a method for analyzing urine constituent substances using ion exchange chromatography, which eliminates the drawbacks of the conventional techniques, improves detection accuracy, expands the detection wavelength range, and significantly shortens analysis time. There is something to do.
前記目的を達成するため、本発明は、溶離液濃度を分析
時間の経過とともに変化させる所謂こう配溶離イオン交
換クロマトグラフイーを適用した尿構成物質類の分析方
法に釦いて、前記溶離液として塩化物とアセトニトリル
を含む水溶液を用い、該水溶液中の塩化物卦よびアセト
ニトリル濃度を連続的または段階的にそれぞれ0.00
1Mから3、OMおよびO、1容量饅から30容量%t
で変化させることを特徴とする。In order to achieve the above object, the present invention provides a method for analyzing urine constituent substances applying so-called gradient elution ion exchange chromatography in which the concentration of the eluent changes with the passage of analysis time, and in which chloride is used as the eluent. Using an aqueous solution containing acetonitrile and acetonitrile, the concentrations of chloride and acetonitrile in the aqueous solution were adjusted continuously or stepwise to 0.00, respectively.
1M to 3, OM and O, 1 volume to 30 volume%t
It is characterized by changing.
本発明に釦いて、分析の対象となる尿構成物質類は、尿
構成物質をはじめ生体関連物質、核酸等の各種有機酸を
広く含む。According to the present invention, the urine constituents to be analyzed broadly include urine constituents, biologically related substances, and various organic acids such as nucleic acids.
渣た、分析方法は、溶離液を本発明構成とする以外は従
来のこう配溶離イオンクロマトグラフイーの手法、装置
をその渣\適用すればよい。As for the analysis method of the residue, conventional gradient elution ion chromatography techniques and apparatuses may be applied to the residue, except that the eluent is configured according to the present invention.
な督、通常用いる陰イオン交換樹脂充填分離カラムの前
段に、陽イオン交換樹脂充填分離カラムを付加する等の
変型は必要に応じて実施すればよい。However, modifications such as adding a separation column packed with a cation exchange resin upstream of a separation column packed with a commonly used anion exchange resin may be carried out as necessary.
溶離液の調整は、従来法に従って塩化物とアセトニトリ
ルをそれぞれ低濃度(アセトニトリルがOの場合もある
)で含む水溶液(初期液)と高濃度で含む水溶液(最終
液)を用意し、これらをグラジエント装置で処理して溶
離液濃度を分析時間の経過とともに連続的に高めて行く
方法でもよく、1た、段階的に濃度を変えた溶離液を用
意臥 これらを順次使用する方法でもよい。To prepare the eluent, prepare an aqueous solution containing chloride and acetonitrile at a low concentration (in some cases, the acetonitrile is O) and a high concentration (final solution), respectively, according to the conventional method. A method may be employed in which the concentration of the eluent is continuously increased over the course of the analysis time by processing the eluent in an apparatus, or a method in which eluent having a stepwise concentration is prepared and used sequentially is also possible.
前記溶離液の調整あるいは送液に先立って、塩化物むよ
びアセトニトリルを含渣ない水を一定時間送液すること
が分離カラムの平衡を保つ上から望捷しい。Prior to adjusting or feeding the eluent, it is desirable to feed water that does not contain chloride or acetonitrile for a certain period of time in order to maintain the equilibrium of the separation column.
溶離液の戒分として用いる塩化物は、水溶性の無機塩化
物から広く選択される八特に塩化アンモニウム、塩化ナ
トリウム、塩化カリウムが好ましい。The chloride used as a component of the eluent is widely selected from water-soluble inorganic chlorides, with ammonium chloride, sodium chloride, and potassium chloride being particularly preferred.
溶離液中の塩化物濃度は、分析時間の経過とともに0.
001Mから3. 0 Mtで変化させることが望捷し
い。The chloride concentration in the eluent decreases to 0 over the course of analysis time.
001M to 3. It is desirable to change it at 0 Mt.
0.OOIMより低濃度では本発明効果が十分でなく、
また3.0Mより高濃度ではカラムの再生を含む後処理
に時間を要する等のため好筐しくない。0. At a concentration lower than OOIM, the effect of the present invention is not sufficient,
Further, a concentration higher than 3.0M is not favorable because post-processing including column regeneration takes time.
1た、アセトニトリルの濃度は、分析時間の経過ととも
に0.1容量多から30容量多!で変化させることが望
1しい。1. The concentration of acetonitrile increases from 0.1 volume to 30 volumes over the course of analysis time! It is desirable to change the
0.1容量俸より低濃度では本発明効果が十分でた〈、
1た30容量φを越えて使用しても格別効果の向上はな
い。The effect of the present invention was sufficient at a concentration lower than 0.1 volume.
Even if the capacity exceeds 1 or 30 φ, there is no particular improvement in the effect.
前記必須成分以外に、調整あるいは助剤として他の戒分
例えばメチルアルコール エチルアルコール等を添加
することは必要に応じて実施すればよい。In addition to the above-mentioned essential components, other substances such as methyl alcohol and ethyl alcohol may be added as adjustments or auxiliaries as necessary.
前記アルコール類の添加量は、分析時間の経過とともに
0.5容量多から30容量多の範囲で変化させればよい
。The amount of the alcohol added may be changed in the range of 0.5 volumes to 30 volumes over the course of the analysis time.
以下、図面に示す態様例により本発明をさらに詳しく説
明する。Hereinafter, the present invention will be explained in more detail with reference to embodiments shown in the drawings.
第1図に示す装置は、本発明にも適用可能な従来の液体
クロマトグラフイーを示すもので、塩化物とアセトニト
リルを低濃度で含む水溶液(初期液)用貯槽IA,同高
濃度で含む水溶液(最終液)用貯槽IB,貯槽1Aおよ
び1Bの溶離液を分析時間の経過に応じて混合調整する
ためのどラジエント装置8、グラジエント装置から導か
れる液を試料注入口3を経て分離カラム4に送るための
ポンプ2、分離カラム4から排出される液を遂次検出す
るための一般に紫外吸光々度計で代表される検出器5、
検出器5からの信号に基づいて作動する記録計6から主
として構威されている。The apparatus shown in FIG. 1 shows conventional liquid chromatography that can be applied to the present invention, including a storage tank IA for an aqueous solution (initial solution) containing chloride and acetonitrile at low concentrations, and an aqueous solution containing high concentrations of chloride and acetonitrile. A gradient device 8 is used to mix and adjust the eluent in the (final solution) storage tank IB, storage tanks 1A and 1B according to the passage of analysis time, and the liquid led from the gradient device is sent to the separation column 4 through the sample injection port 3. a detector 5, generally represented by an ultraviolet absorbance meter, for sequentially detecting the liquid discharged from the separation column 4;
It mainly consists of a recorder 6 that operates based on the signal from the detector 5.
なお、図中7は検出後の排出液を、筐た9は水の注入口
を示す。In the figure, 7 indicates the discharged liquid after detection, and the casing 9 indicates a water inlet.
前記構成の装置に釦いて、試料注入口3から供給される
尿等の試料+4注入口9、ポンプ2を介して送られる水
で予め平衡とされた分離カラムに導かれ、その構成成分
は該カラムに充填された陰イオン交換樹脂に吸収される
。When the device configured as described above is pressed, a sample of urine or the like supplied from the sample inlet 3 + 4 is introduced into a separation column that has been equilibrated in advance with water sent through the inlet 9 and the pump 2, and its constituent components are It is absorbed by the anion exchange resin packed in the column.
しかる後にグラジエント装置8を始動させ、かくするこ
とにより、陰イオン交換樹脂に吸収された尿構成物質は
それぞれの戒分に分離されて順次検出器5に到達し、こ
こで各成分の量に応じた信**号が発信され、記録計6
に記録される。Thereafter, the gradient device 8 is started, whereby the urine constituents absorbed by the anion exchange resin are separated into their respective components and reach the detector 5 in sequence, where they are separated according to the amount of each component. A signal** signal was sent out, and a total of 6 records were recorded.
recorded in
次に、第7図に示す装置屯第1図に示す各貯槽とグラジ
エント装置の組合せに代えて濃度を段階的に変化させた
溶離液の貯槽IC , ID , IEIF,IG,I
Hとこれら各槽の切替弁10を設ける以外は同様な構成
としたものであり、か\る構成の装置による場合でも切
替弁10により各槽の溶離液を低濃度から高濃度へ順次
変化させ得るので同様にして分析することが可能となる
。Next, in place of the apparatus shown in FIG. 7 and the combination of each storage tank and gradient device shown in FIG.
The configuration is the same except that H and a switching valve 10 for each tank are provided, and even in the case of an apparatus with such a configuration, the eluent in each tank can be sequentially changed from low concentration to high concentration by the switching valve 10. Therefore, it is possible to analyze in the same way.
以下、実施例により本発明の作用効果をさらに詳しく説
明する。Hereinafter, the effects of the present invention will be explained in more detail with reference to Examples.
比較例
第1図に示す装置に基づき、既述瀬田等の方法によりか
つ第1表に示す条件で尿の分析を行なった。Comparative Example Based on the apparatus shown in FIG. 1, urine was analyzed according to the method of Seta et al. and under the conditions shown in Table 1.
分析の結果、第2図のクロマトグラムが得られた。As a result of the analysis, the chromatogram shown in FIG. 2 was obtained.
図中、Aは尿酸、Bは馬尿酸、Cはインドール酢酸の各
ピークを示す。In the figure, A shows the peaks of uric acid, B shows the peaks of hippuric acid, and C shows the peaks of indoleacetic acid.
吸光度のベースラインが時間の経過とともに上昇してい
るため精度が著しく劣ること、分析時間に2時間を要し
長過ぎること等の欠点が知られた。It has been known that the method has disadvantages such as significantly lower accuracy because the baseline of absorbance increases with the passage of time, and that the analysis time is too long, requiring 2 hours.
実施例 1
0.006Mの酢酸一酢酸アンモニウムからなる初期液
に代えO.OOIMの塩化アンモニウム水溶液を、lた
6. O Mの酢酸一酢酸アンモニウムからなる最終液
に代え2、OM塩化アンモニウムと30溶量多のアセト
ニトリルからなる混合水溶液を用いる以外は比較例と同
一条件にて実施し、第3図に示すクロマトグラムを得た
。Example 1 In place of the initial solution consisting of 0.006M ammonium acetate monoacetate, O. 6. Add 1 liter of ammonium chloride solution of OOIM. The experiment was carried out under the same conditions as in the comparative example, except that instead of the final solution consisting of OM ammonium acetate monoacetate, a mixed aqueous solution consisting of 2, OM ammonium chloride and acetonitrile in a 30 solvable amount was used, and the chromatogram shown in Fig. 3 was obtained. I got it.
図中、Aは尿酸、Bは馬尿酸、Cはインドール酢酸の各
ピークを示す。In the figure, A shows the peaks of uric acid, B shows the peaks of hippuric acid, and C shows the peaks of indoleacetic acid.
第3図から明らかなように、本実施例によれば時間の経
過にともなうベースラインの上昇はなくかつ分析時間も
1時間と大巾に短縮されることが明らかとなった。As is clear from FIG. 3, according to this example, there was no increase in the baseline over time and the analysis time was significantly shortened to 1 hour.
前記ベースラインの上昇をともなわない理由は、本発明
では紫外吸収性の酢酸系溶離液を使用しないためと考え
られる。The reason why the baseline does not increase is considered to be that the present invention does not use an ultraviolet-absorbing acetic acid eluent.
ちなみに、溶離液として酢酸系の緩衝液を使用する場合
と本発明の溶離液を用いる場合とについて、紫外透過率
と波長との関係を求めたところそれぞれ第4図および第
5図の結果が得られた。Incidentally, when we determined the relationship between ultraviolet transmittance and wavelength when an acetic acid buffer was used as the eluent and when the eluent of the present invention was used, the results shown in Figures 4 and 5 were obtained, respectively. It was done.
ナ釦、図中、20は酢酸一酢酸アンモニウムの濃度が0
. 0 0 .I Mの場合(初期液)、21は同0.
1 M、22は同6.0M(最終液)の場合を示し、
1た、30は塩化アンモニウム濃度が0.001Mの場
合(初期液)、31は塩化アンモニウム濃度が0.75
M,アセトニトリル濃度力、:5容量宏32は塩化アン
モニウム濃度が3, O M,アセトニトリル濃度が1
5容量φの場合(最終液)をそれぞれ示す。Na button, 20 in the figure indicates the concentration of ammonium acetate monoacetate is 0.
.. 0 0. In the case of IM (initial solution), 21 is the same as 0.
1 M, 22 indicates the case of 6.0 M (final solution),
1, 30 is when the ammonium chloride concentration is 0.001M (initial solution), 31 is when the ammonium chloride concentration is 0.75
M, acetonitrile concentration: 5 Capacity Hiroshi 32 has an ammonium chloride concentration of 3, O M, acetonitrile concentration is 1
The case of 5 volumes φ (final liquid) is shown.
各図から明らかなように、いずれの場合も溶離液濃度が
高くなるにつれて吸収増大時の波長は長波長側へ移動す
るが、本発明(第5図参照)では最終液でも2 2 0
nm程度迄は大きな吸収を示さないのに反し、従来法
では2 5 0 nmでも吸収が大きくなるという特徴
を有している。As is clear from each figure, in any case, as the eluent concentration increases, the wavelength at which absorption increases shifts to the longer wavelength side, but in the present invention (see Figure 5), even the final solution has a wavelength of 2 20
On the other hand, the conventional method has the characteristic that absorption is large even at 250 nm, whereas it does not show large absorption up to about 250 nm.
このことは、本発明によれば溶離液の濃度が高くなって
も(換言すれば時間が経過しても)通常使用される波長
、例えば2 5 4 nmあるいは2 8 0 nmで
はベースラインの上昇を来たさないばかりか、より低波
長の利用も可能であることを示唆するものである。This means that, according to the present invention, even if the concentration of the eluent increases (in other words, even with the passage of time), the baseline rises at commonly used wavelengths, such as 254 nm or 280 nm. This suggests that not only does it not cause a problem, but it is also possible to use lower wavelengths.
また、本発明により分析時間が短縮される点について考
察するに、本発明で使用する塩化物から生ずる塩素イオ
ンは強塩基性陰イオン交換樹脂に神1対する選択係数が
従来の酢酸イオンよりも約10倍大きいこと訃よび塩化
物と共存せしめるアセトニトリルの作用により、溶質の
移動相への溶解度が高められることの相乗効果に起因す
るものと考えられる。Furthermore, considering the fact that the analysis time is shortened by the present invention, the chloride ion generated from the chloride used in the present invention has a selectivity coefficient of about 1 for strongly basic anion exchange resins compared to the conventional acetate ion. This is thought to be due to the synergistic effect of increasing the solubility of the solute in the mobile phase due to the action of acetonitrile coexisting with chloride and the 10 times larger amount.
実施例 2
0.001M塩化アンモニウム水溶液に代え0.03M
塩化ナトリウム水溶液を、寸た3.OM塩化アンモニウ
ム−15容量多アセトニトリルの混合水溶液に代え2.
0 M塩化ネトリウム−30容量多アセトニトリルの
混合水溶液を用いる以外は実施例1と同様にして実施し
、第6図に示すクロマトグラムを得た。Example 2 0.03M instead of 0.001M ammonium chloride aqueous solution
3. Dilute the sodium chloride aqueous solution. 2. Replaced with a mixed aqueous solution of OM ammonium chloride-15 volumes of acetonitrile.
The procedure was carried out in the same manner as in Example 1 except that a mixed aqueous solution of 0 M netrium chloride and 30 volumes of acetonitrile was used, and the chromatogram shown in FIG. 6 was obtained.
図中、Aは尿酸、Bは馬尿酸、Cはインドール酢酸の各
ピークを示す。In the figure, A shows the peaks of uric acid, B shows the peaks of hippuric acid, and C shows the peaks of indoleacetic acid.
第6図から明らかなように、本実施例によれば実施例1
と同様な効果が達成された。As is clear from FIG. 6, according to this example, Example 1
A similar effect was achieved.
実施例 3
第7図に示す装置の各貯槽1C〜1Hに第4表に示す組
或の各溶離液を満した後、切替弁10を作動させて同表
に示す送液時間で各液を順次通液する以外は実施例1釦
よび2と同様にして腎疾患者尿の分析を実施し、第8図
に示すクロマトグラムを得た。Example 3 After filling each storage tank 1C to 1H of the apparatus shown in FIG. 7 with each eluent in the set shown in Table 4, the switching valve 10 was operated to feed each liquid for the liquid delivery time shown in the table. Analysis of urine from patients with renal disease was carried out in the same manner as in Examples 1 and 2, except that the liquids were passed sequentially, and the chromatogram shown in FIG. 8 was obtained.
第8図から明らかなように、本実施例による場合も、実
施例1むよび2と同様な効果の達成されることが知られ
た。As is clear from FIG. 8, it has been found that the same effects as in Examples 1 and 2 can be achieved in this example as well.
以上説明したように、本発明によれば、従来の分析方法
では不可能であった2 5 0 nm以短の波長域にあ
る紫外線を吸収する尿構成物質の検出が可能になること
、溶離液の流速が従来法と同程度であっても分析時間を
従来の2時間から1時間程度へ大巾に短縮できること、
ベースラインが分析時間の経過にともなって上昇しない
ため、各成分の定量精度が向上する上に検出器の感度を
大巾(数十倍)に上げ得るので微量成分の検出も可能に
なる等の種々の効果が達成される。As explained above, according to the present invention, it is possible to detect urine constituent substances that absorb ultraviolet rays in the wavelength range of 250 nm or shorter, which was impossible with conventional analysis methods, and that it is possible to detect Even if the flow rate is the same as that of the conventional method, the analysis time can be significantly shortened from the conventional 2 hours to about 1 hour.
Since the baseline does not rise as the analysis time passes, the quantitative accuracy of each component is improved, and the sensitivity of the detector can be greatly increased (several tens of times), making it possible to detect trace components. Various effects are achieved.
第1図は本発明に適用可能な従来液体クロマトグラフイ
ー例の系統図、第2図は従来法により得られるクロマト
グラム、第3図は本発明実施例により得られるクロマト
グラム、第4図は従来溶離液使用下での紫外吸収特性図
、第5図は本発明溶離液使用下での紫外吸収特性図、第
6図は本発明実施他例により得られるクロマトグラム、
第7図ハ本発明による液体クロマトグラフィー例の系統
図、第8図は本発明の他の実施例により得られるクロマ
トグラムである。
1A・・・初期液貯槽、1B・・・最終液貯槽、1C,
1D,IE,1F,IG,IH・・・溶離液貯槽、2・
・・ポンプ、3・・・試料注入口、4・・・分離カラム
、5・・・検出器、6・・・記録計、7・・・排出液、
8・・・グラジエント装置、9・・・水注入口、10・
・・切替弁、20・・・酢酸一酢酸アンモニウム0.0
01M,21・・・酢酸一酢酸アンモニウム0. 1
M、22・・・酢酸一酢酸アンモニウム6.0M,30
・・・塩化アンモニウム0.0 0 1M, 3 1
・・・塩化アンモニウム0.75M−アセトニトリル5
%、3 2・・・塩化アンモニウム3,OM−アセトニ
トリル15饅。Fig. 1 is a system diagram of an example of conventional liquid chromatography applicable to the present invention, Fig. 2 is a chromatogram obtained by the conventional method, Fig. 3 is a chromatogram obtained by the embodiment of the present invention, and Fig. 4 is a system diagram of an example of conventional liquid chromatography applicable to the present invention. FIG. 5 is an ultraviolet absorption characteristic diagram using a conventional eluent, FIG. 5 is an ultraviolet absorption characteristic diagram using an eluent of the present invention, and FIG. 6 is a chromatogram obtained by another example of the present invention.
FIG. 7 is a system diagram of an example of liquid chromatography according to the present invention, and FIG. 8 is a chromatogram obtained by another example of the present invention. 1A...Initial liquid storage tank, 1B...Final liquid storage tank, 1C,
1D, IE, 1F, IG, IH... Eluent storage tank, 2.
... Pump, 3... Sample injection port, 4... Separation column, 5... Detector, 6... Recorder, 7... Effluent,
8... Gradient device, 9... Water inlet, 10.
...Switching valve, 20...Ammonium acetate monoacetate 0.0
01M, 21... Ammonium acetate monoacetate 0. 1
M, 22...Ammonium acetate monoacetate 6.0M, 30
...Ammonium chloride 0.0 0 1M, 3 1
...Ammonium chloride 0.75M-acetonitrile 5
%, 3 2...Ammonium chloride 3, OM-acetonitrile 15 cups.
Claims (1)
う配溶離イオン交換クロマトグラフイーを適用した尿構
成物質類の分析方法にち・いて、前記溶離液として塩化
物とアセトニトリルを含む水溶液を用い、該水溶液中の
上記塩化物濃度を0.0 01モルから3.0モルの間
で連続的1たは段階的に変化させ、上記アセトニトリル
濃度を0.1容量パーセントから30容量パーセントの
間で連続的1たは段階的に変化させることを特徴とする
尿構或物質類の分析方法。1. In a method for analyzing urine constituent substances applying gradient elution ion exchange chromatography in which the concentration of the eluent changes with the passage of analysis time, an aqueous solution containing chloride and acetonitrile is used as the eluent, and the aqueous solution The chloride concentration in the solution was varied continuously or stepwise from 0.001 mol to 3.0 mol, and the acetonitrile concentration was continuously varied from 0.1 volume percent to 30 volume percent. A method for analyzing urinary composition or substances characterized by stepwise change.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1046179A JPS5848064B2 (en) | 1979-02-02 | 1979-02-02 | Analysis method for urine constituent substances |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1046179A JPS5848064B2 (en) | 1979-02-02 | 1979-02-02 | Analysis method for urine constituent substances |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55103462A JPS55103462A (en) | 1980-08-07 |
| JPS5848064B2 true JPS5848064B2 (en) | 1983-10-26 |
Family
ID=11750767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1046179A Expired JPS5848064B2 (en) | 1979-02-02 | 1979-02-02 | Analysis method for urine constituent substances |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5848064B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59217844A (en) * | 1983-05-26 | 1984-12-08 | 東陶機器株式会社 | Toilet apparatus |
| JPS6263859A (en) * | 1985-09-13 | 1987-03-20 | Shimadzu Corp | Automatic analyzer for homovanillic acid and vanilmandelic acid |
| CN107261846B (en) * | 2017-06-21 | 2021-03-09 | 中国科学院过程工程研究所 | Method for continuously separating enriched boron isotopes by ion exchange chromatography based on gradient elution |
| JP7740928B2 (en) * | 2021-07-30 | 2025-09-17 | 株式会社日立ハイテクアナリシス | Method for controlling an ion exchange chromatograph and an ion exchange chromatograph |
-
1979
- 1979-02-02 JP JP1046179A patent/JPS5848064B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS55103462A (en) | 1980-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scott et al. | Automatic, high-resolution analysis of urine for its ultraviolet-absorbing constituents. | |
| Alvarez-Coque et al. | Direct injection of physiological fluids in micellar liquid chromatography | |
| Lauff et al. | Quantitative liquid-chromatographic estimation of bilirubin species in pathological serum. | |
| Roth | Fluorimetric determination of free hydroxyproline and proline in blood plasma | |
| Cooper et al. | Automated sequential trace enrichment of dialysates and robotics: a technique for the preparation of biological samples prior to high-performance liquid chromatography | |
| WO2012057676A1 (en) | Chromatography system with guard columns | |
| Koohpaei et al. | Optimization of solid-phase extraction using developed modern sorbent for trace determination of ametryn in environmental matrices | |
| JPS5848064B2 (en) | Analysis method for urine constituent substances | |
| Jacobsen et al. | Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding | |
| Senftleber et al. | Reversed-phase liquid-chromatographic analysis of hemodialysate from uremic patients. | |
| Tahara et al. | Determination of antihyperglycemic biguanides in serum and urine using an ion‐pair solid‐phase extraction technique followed by HPLC‐UV on a pentafluorophenylpropyl column and on an octadecyl column | |
| EP1287356A1 (en) | Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient | |
| Emara | Simultaneous determination of caffeine, theophylline and theobromine in human plasma by on‐line solid‐phase extraction coupled to reversed‐phase chromatography | |
| CN110412185B (en) | Method for measuring six ions in urine by online dialysis-double inhibition ion chromatography | |
| Scott et al. | Advances in the application of high resolution liquid chromatography to the separation of complex biological mixtures | |
| Liu | Measurement of blood plasma amino acids in ultrafiltrates by high-performance liquid chromatography with automatic precolumn o-phthaldialdehyde derivatization | |
| JP2015517092A (en) | Material purification device | |
| JPS648303B2 (en) | ||
| CN119912556A (en) | Method for stabilizing hemoglobin A2 and hemoglobin F, method for producing hemoglobin solution, and hemoglobin solution | |
| Wolf et al. | The extracellular concentration of the anti-epileptic drug valproate in the rat brain as determined with microdialysis and an automated HPLC procedure | |
| EP0588335B1 (en) | Separation column and method for preventing its deterioration | |
| JPH0792154A (en) | Glyphosate analysis method in agricultural products | |
| US12521647B2 (en) | Method for purifying a target substance with viral inactivation | |
| US4914036A (en) | Method and apparatus for simultaneously analyzing vanillylmandelic acid, homovanillic acid and creatinine | |
| JP2825403B2 (en) | Method, apparatus and reagents for measuring catecholamines and their metabolites |